Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.

Auteurs

Beaulieu M, Gaymard A, Massonnaud C, Peiffer-Smadja N, Bouscambert-Duchamp M, Carcelain G, Lingas G, Mentré F, Ader F, Hites M, Poignard P, Guedj J

  • Date de publication

    September 2024

  • Type

    Article

  • Review

    J Antimicrob Chemother

  • Researcher's name

    Hites Maya

  • Hôpital

    Hôpital Erasme

  • Service

    Médecine Interne

  • PMID

    39236218

  • DOI

    10.1093/jac/dkae301